Design and evaluation of a zero-order controlled release system based on pre-hydrated constant release area prepared by compression coating technology
The main aim of this research work was to develop and evaluate a drug delivery system with compression coating technology to control drug release at a constant rate. The compression coated tablets (CCTs) consist of the hydrophilic matrix core and the hydrophobic waxy coating. The presence of hydrophobic waxy coating could provide sufficient time for hydration of the core to prevent initial burst release. The mechanism research revealed that erosion was the main way of drug release and the releasing area was constant during the entire release process because the core tablet was located in the cup-shaped coating after one side cover was dropped at the lag time. This made the release behavior exhibit zero-order kinetics (R2>0.99). The coating rupture strength and the core swelling force at the lag time influenced erosion rate thus affecting release rate. Different solubility of drugs (propranolol hydrochloride, melatonin, and nifedipine) was selected as model drugs and the properties of the prepared CCTs in terms of formulations and in vitro release were evaluated. The release rate was independent of solubility, medium pH, and osmotic pressure. This zero-order controlled system could be applied to both controlled drug delivery and chrono pharmaceutical drug delivery.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Pharmaceutical development and technology - 26(2021), 10 vom: 26. Dez., Seite 1120-1129 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Qinying [VerfasserIn] |
---|
Links: |
---|
Themen: |
9004-34-6 |
---|
Anmerkungen: |
Date Completed 11.02.2022 Date Revised 11.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/10837450.2021.1998912 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM332386635 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM332386635 | ||
003 | DE-627 | ||
005 | 20231225215452.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10837450.2021.1998912 |2 doi | |
028 | 5 | 2 | |a pubmed24n1107.xml |
035 | |a (DE-627)NLM332386635 | ||
035 | |a (NLM)34698603 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Qinying |e verfasserin |4 aut | |
245 | 1 | 0 | |a Design and evaluation of a zero-order controlled release system based on pre-hydrated constant release area prepared by compression coating technology |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.02.2022 | ||
500 | |a Date Revised 11.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The main aim of this research work was to develop and evaluate a drug delivery system with compression coating technology to control drug release at a constant rate. The compression coated tablets (CCTs) consist of the hydrophilic matrix core and the hydrophobic waxy coating. The presence of hydrophobic waxy coating could provide sufficient time for hydration of the core to prevent initial burst release. The mechanism research revealed that erosion was the main way of drug release and the releasing area was constant during the entire release process because the core tablet was located in the cup-shaped coating after one side cover was dropped at the lag time. This made the release behavior exhibit zero-order kinetics (R2>0.99). The coating rupture strength and the core swelling force at the lag time influenced erosion rate thus affecting release rate. Different solubility of drugs (propranolol hydrochloride, melatonin, and nifedipine) was selected as model drugs and the properties of the prepared CCTs in terms of formulations and in vitro release were evaluated. The release rate was independent of solubility, medium pH, and osmotic pressure. This zero-order controlled system could be applied to both controlled drug delivery and chrono pharmaceutical drug delivery | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Zero-order release | |
650 | 4 | |a compression coated tablet | |
650 | 4 | |a erosion | |
650 | 4 | |a release mechanism | |
650 | 4 | |a time-controlled release | |
650 | 7 | |a Delayed-Action Preparations |2 NLM | |
650 | 7 | |a Tablets |2 NLM | |
650 | 7 | |a Cellulose |2 NLM | |
650 | 7 | |a 9004-34-6 |2 NLM | |
700 | 1 | |a Jiao, Jie |e verfasserin |4 aut | |
700 | 1 | |a Cai, Qingchun |e verfasserin |4 aut | |
700 | 1 | |a Wang, Qiaochu |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Wei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmaceutical development and technology |d 1998 |g 26(2021), 10 vom: 26. Dez., Seite 1120-1129 |w (DE-627)NLM094740194 |x 1097-9867 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2021 |g number:10 |g day:26 |g month:12 |g pages:1120-1129 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/10837450.2021.1998912 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2021 |e 10 |b 26 |c 12 |h 1120-1129 |